Mainz Biomed N.V Income Statement (2020-2025) | MYNZ

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2020 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Jun2024 Dec2024 Jun2025
Revenue & cost
Revenue 10.04M0.10M0.14M0.10M0.19M0.25M0.25M0.18M0.21M8.45M13.24M9.80M
Cost of Revenue 0.05M0.06M0.08M0.16M0.11M0.10M0.09M0.08M
Gross Profit 0.05M0.08M0.02M0.04M0.14M0.15M0.09M0.13M
Operating items
Research & Development 0.56M0.23M0.91M3.32M2.63M3.48M1.85M2.00M
Selling, General & Administrative 4.19M4.93M3.98M2.11M1.59M2.80M2.75M3.78M
Other Operating Expenses -0.03M0.01M-0.12M0.20M-0.07M-0.33M-0.66M0.33M-1.42M0.09M-0.36M
Operating Expenses 5.68M7.03M5.49M8.43M6.63M8.07M5.73M6.73M
Operating Income -5.63M-6.95M-5.48M-8.39M-6.49M-7.93M-5.64M-6.59M
EBIT -5.63M-6.95M-5.48M-8.39M-6.49M-7.93M-5.64M-6.59M
Non-operating items
Other Non Operating Income 0.13M0.57M
Net income details
EBT -5.66M-6.94M-5.60M-8.19M-6.56M-8.25M-6.30M-5.18M
Profit After Tax -5.66M6.94M-5.60M-8.19M-6.56M-8.25M-6.30M-5.18M
Investment Income 0.04M0.05M0.06M-0.06M-0.09M0.48M-0.84M
Income from Continuing Operations -5.66M-6.94M-5.60M-8.19M-6.56M-8.25M-6.30M-5.18M
Consolidated Net Income -5.66M-6.94M-5.60M-8.19M-6.56M-8.25M-6.30M-5.18M
Income towards Parent Company -5.66M-6.94M-5.60M-8.19M-6.56M-8.25M-6.30M-5.18M
Net Income towards Common Stockholders -5.66M-6.94M-5.60M-8.19M-6.56M-8.25M-6.30M-5.18M
Additional items
EPS (Basic) -19.35-23.11-15.46-22.62-18.12-22.26-15.05-12.38
EPS (Weighted Average and Diluted) -0.58-12.76
Shares Outstanding (Weighted Average) 0.29M0.29M0.29M0.30M0.36M0.36M0.36M0.37M0.42M0.42M0.53M0.64M2.32M
Shares Outstanding (Diluted Average) 5.61M7.21M14.16M0.41M0.97M
EBITDA 5.63M6.89M5.53M-8.39M6.62M8.34M5.82M6.02M
Interest Expenses 0.02M0.02M0.02M0.18M0.04M0.07M0.03M0.39M